SNNAQ (Sienna Biopharmaceuticals) Research & Development: $26.77 Mil (TTM As of Sep. 2019)


What is Sienna Biopharmaceuticals Research & Development?

Sienna Biopharmaceuticals SNNAQ -99.00% Research & Development is $26.77 Mil as of Sep. 2019.

Research & Development is the aggregate amount of research and development expenses during the year. Sienna Biopharmaceuticals's Research & Development for the three months ended in Sep. 2019 was $3.82 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Sep. 2019 was $26.77 Mil.

Sienna Biopharmaceuticals  (OTCPK:SNNAQ) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Sienna Biopharmaceuticals Research & Development Related Terms

Sienna Biopharmaceuticals Research & Development Historical Data

* Premium members only.

The historical data trend for Sienna Biopharmaceuticals's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sienna Biopharmaceuticals Research & Development Chart

Sienna Biopharmaceuticals Annual Data
Trend Dec15 Dec16 Dec17 Dec18
Research & Development
2.41 10.99 30.48 51.59

Sienna Biopharmaceuticals Quarterly Data
Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.15 10.77 7.09 5.08 3.82

Sienna Biopharmaceuticals Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Sep. 2019 adds up the quarterly data reported by the company within the most recent 12 months, which was $26.77 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $26.77 Mil mean?
Sienna Biopharmaceuticals (SNNAQ) has a Research & Development of $26.77 Mil as of Sep. 2019. Research and development expense is the total cost for research and development activities. View historical data on Sienna Biopharmaceuticals and its competitors.
Is Sienna Biopharmaceuticals' Research & Development too high?
Sienna Biopharmaceuticals' current Research & Development is $26.77 Mil.
How does Sienna Biopharmaceuticals' Research & Development compare to GTHR and PPCB?
Sienna Biopharmaceuticals' Research & Development of $26.77 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Biotechnology company?
A good Research & Development depends on the Biotechnology industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Sienna Biopharmaceuticals and its competitors. Sienna Biopharmaceuticals's current Research & Development is $26.77 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sienna Biopharmaceuticals stock overvalued right now?
Sienna Biopharmaceuticals (SNNAQ) has a current Research & Development of $26.77 Mil. The current Research & Development is $26.77 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Sienna Biopharmaceuticals (SNNAQ), the current Research & Development is $26.77 Mil as of Sep. 2019. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Sienna Biopharmaceuticals Business Description

Address 30699 Russell Ranch Road, Suite 140, Westlake Village, CA, USA, 91362
Sienna Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on bringing innovations in biotechnology to the discovery, development, and commercialization of first-in-class, targeted, topical products in medical dermatology and aesthetics. The objective is to develop multi-asset pipeline of topical therapies that enhance the health, appearance, and quality of life of dermatology patients. The product portfolio includes SNA-120, SNA-125, and SNA-001.